A phase I/II study of the safety and efficacy of the addition of sirolimus to tacrolimus/methotrexate graft versus host disease prophylaxis after allogeneic haematopoietic cell transplantation in paediatric acute lymphoblastic leukaemia (ALL).

A phase I/II study of the safety and efficacy of the addition of sirolimus to tacrolimus/methotrexate graft versus host disease prophylaxis after allogeneic haematopoietic cell transplantation in paediatric acute lymphoblastic leukaemia (ALL).

Item
http://www.wikidata.org/entity/Q33924570
Children's Oncology Group's 2013 blueprint for research: stem cell transplantation.Sirolimus pharmacokinetics in early postmyeloablative pediatric blood and marrow transplantation.Strategies to prevent EBV reactivation and posttransplant lymphoproliferative disorders (PTLD) after allogeneic stem cell transplantation in high-risk patients.High-risk pediatric acute lymphoblastic leukemia: to transplant or not to transplant?Mammalian target of rapamycin (mTOR) activity dependent phospho-protein expression in childhood acute lymphoblastic leukemia (ALL)Characteristic mTOR activity in Hodgkin-lymphomas offers a potential therapeutic target in high risk disease--a combined tissue microarray, in vitro and in vivo study.Risk factors and timing of relapse after allogeneic transplantation in pediatric ALL: for whom and when should interventions be tested?Is pimecrolimus cream (1%) an appropriate therapeutic agent for the treatment of external ear atopic dermatitis?Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics of Immunosuppressants in Allogeneic Hematopoietic Cell Transplantation: Part II.Should methotrexate plus calcineurin inhibitors be considered standard of care for prophylaxis of acute graft-versus-host disease?The addition of sirolimus to tacrolimus/methotrexate GVHD prophylaxis in children with ALL: a phase 3 Children's Oncology Group/Pediatric Blood and Marrow Transplant Consortium trial.The efficacy and safety of sirolimus-based graft-versus-host disease prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation: a meta-analysis of randomized controlled trials.Metabolic reprogramming of alloantigen-activated T cells after hematopoietic cell transplantationHaploidentical stem cell transplantation augmented by CD45RA negative lymphocytes provides rapid engraftment and excellent tolerability.
P2860

A phase I/II study of the safety and efficacy of the addition of sirolimus to tacrolimus/methotrexate graft versus host disease prophylaxis after allogeneic haematopoietic cell transplantation in paediatric acute lymphoblastic leukaemia (ALL).

Item
http://www.wikidata.org/entity/Q33924570
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
A phase I/II study of the safe ...... lymphoblastic leukaemia (ALL).
@ast
A phase I/II study of the safe ...... lymphoblastic leukaemia (ALL).
@en
type
label
A phase I/II study of the safe ...... lymphoblastic leukaemia (ALL).
@ast
A phase I/II study of the safe ...... lymphoblastic leukaemia (ALL).
@en
prefLabel
A phase I/II study of the safe ...... lymphoblastic leukaemia (ALL).
@ast
A phase I/II study of the safe ...... lymphoblastic leukaemia (ALL).
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
A phase I/II study of the safe ...... lymphoblastic leukaemia (ALL).
@en
P2093
P2860
P304
P31
P356
10.1111/J.1365-2141.2009.07889.X
P407
P433
P478
P577
P5875
P698
P921
P932